@misc{indiciaed3d5ac77a058,
  title = {Discovery and characterization of FX-909, a covalent inverse agonist of PPARG rationally designed to impose a powerful repressive bias in PPARG for the treatment of PPARG/RXRA-activated muscle-invasive urothelial cancers},
  author = {Stuckey, J. I. and Mertz, J. A. and Wilson, J. E. and Williamson, K. E. and Li, Y. and Kuljanin, M. and DeLaBarre, B. and Chenail, G. and Nguyen, P. A. and Bailey, C. M. and Motley, W. M. and Audia, J. E. and Sims, R. J.},
  year = {2025},
  doi = {10.1101/2025.05.08.652848},
  url = {https://www.biorxiv.org/content/10.1101/2025.05.08.652848v1},
  note = {Source identifier: 10.1101/2025.05.08.652848}
}